Duplicate somatic mutations in specific genes have been identified as potential cancer initiators [72, 73], among which, KRAS, CDKN2A, SMAD4, and TP53 are frequently mutated in PC [74]. This evidence concerns the gene CDKN2A and pachyonychia congenita.